In the last trading session, 1.11 million Health Catalyst Inc (NASDAQ:HCAT) shares changed hands as the company’s beta touched 1.37. With the company’s per share price at $5.90 changed hands at -$0.59 or -9.09% during last session, the market valuation stood at $359.00M. HCAT’s last price was a discount, traded about -87.46% off its 52-week high of $11.06. The share price had its 52-week low at $5.42, which suggests the last value was 8.14% up since then. When we look at Health Catalyst Inc’s average trading volume, we note the 10-day average is 0.55 million shares, with the 3-month average coming to 546.42K.
Analysts gave the Health Catalyst Inc (HCAT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.57. If we narrow down to specifics, the data shows that 0 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended HCAT as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Health Catalyst Inc’s EPS for the current quarter is expected to be 0.08.
Health Catalyst Inc (NASDAQ:HCAT) trade information
Instantly HCAT was in red as seen at the end of in last trading. With action -20.27%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -16.55%, with the 5-day performance at -20.27% in the red. However, in the 30-day time frame, Health Catalyst Inc (NASDAQ:HCAT) is -29.43% down. Looking at the short shares, we see there were 2.64 million shares sold at short interest cover period of 4.5 days.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 34.44% from its current market value. According to analyst projections, HCAT’s forecast low is 7 with 11 as the target high. To hit the forecast high, the stock’s price needs a -86.44% plunge from its current level, while the stock would need to soar -18.64% for it to hit the projected low.
Health Catalyst Inc (HCAT) estimates and forecasts
Data shows that the Health Catalyst Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -9.37% over the past 6 months, a 120.00% in annual growth rate that is considerably higher than the industry average of 24.90%. Year-over-year growth is forecast to reach 3.92% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 80.57M. 9 analysts are of the opinion that Health Catalyst Inc’s revenue for the current quarter will be 83.06M. The company’s revenue for the corresponding quarters a year ago was 75.08M and 74.72M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 7.31%. The estimates for the next quarter sales put growth at 11.15%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.69%. The 2025 estimates are for Health Catalyst Inc earnings to increase by 104.84%.
HCAT Dividends
Health Catalyst Inc is expected to release its next quarterly earnings report in February.
Health Catalyst Inc (NASDAQ:HCAT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.67% of Health Catalyst Inc shares while 90.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 93.30%. There are 90.80% institutions holding the Health Catalyst Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 9.2722% of the shares, roughly 5.43 million HCAT shares worth $34.72 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 7.7263% or 4.53 million shares worth $28.93 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Pax World Small Cap Fund and Vanguard Total Stock Market Index Fund . With 2.55 shares estimated at $15.07 million under it, the former controlled 4.20% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.99% of the shares, roughly 1.82 shares worth around $10.75 million.
